DRAP asks WHO to build consensus to review drugs sales rules.

ISLAMABAD -- The Drugs Regulatory Authority of Pakistan (DRAP) on Wednesday asked the World Health Organization (WHO) to build consensus amongst health departments to review and amend the drugs sales rules.

The letter written to the WHO country head Dr. Palitha Mahipala by the DRAP asked to review, amend and harmonise drugs sales rules (human and veterinary) to ensure supervision only by pharmacists (Category A). The DRAP said that the global action plan on antimicrobial resistance diseases cannot be reduced without amending the rules, and there is...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT